Vertigo Clinical Trial
Official title:
Post-marketing Observational Program of Betaserc® (Betahistine Dihydrochloride) to Evaluate Effectiveness in Patients With Vestibular Vertigo in Routine Practice
The purposes of this international post-marketing observational program is to investigate effectiveness of betahistine dihydrochloride (Betaserc®) tablets and assess the course of vestibular vertigo after treatment discontinuation in population of Russia and Ukraine outpatients suffering from vestibular vertigo in pragmatic clinical settings. Exploratory analyses of results from both participating countries may be expected to provide insights about the subjective circumstances of vestibular vertigo patients in a wider than usual range of gender, underlying ICD-10 diagnosis, national and cultural situations.
A prospective, multicentre, non-interventional, non-randomized, non-controlled, single arm, post-marketing observational program in patients whom betahistine dihydrochloride (Betaserc®) tablets were prescribed in the usual manner at the maximal recommended daily dose of 48 mg in accordance with the locally approved label. Over a program period physician is free to adjust betahistine dihydrochloride dose according to country approved label. Adult outpatients with vestibular vertigo who can be treated with betahistine dihydrochloride as per the locally approved label will be enrolled in the program. The program consists of an observational treatment period (up to 2 months) and a follow-up period (up to 2 months, for evaluation of the course of vestibular vertigo after treatment completion). ;
Time Perspective: Prospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT05649891 -
Checklists Resuscitation Emergency Department
|
N/A | |
| Recruiting |
NCT05533840 -
Establishment and Application of a New Imaging System for Otology Based on Ultra-high Resolution CT
|
||
| Completed |
NCT02533739 -
Vestibular Disorder and Visuo-spatial Functions
|
N/A | |
| Completed |
NCT01153789 -
Study of Oculomotor Dysfunction Leading to Children Vertigo
|
N/A | |
| Completed |
NCT00765635 -
Chlorobutanol, Potassium Carbonate, and Irrigation in Cerumen Removal
|
Phase 4 | |
| Not yet recruiting |
NCT04929444 -
Training to Improve Vertigo Management in Primary Care
|
N/A | |
| Completed |
NCT04458376 -
Internet-based Self-help Program for Vestibular Rehabilitation in Chronic Dizziness
|
N/A | |
| Not yet recruiting |
NCT04055766 -
A Diagnostic Test on DeepDoc-an AI-based Decision Support System
|
||
| Recruiting |
NCT06332326 -
Investigation of the Efficacy of Non-Invasive Vagus Nerve Stimulation and Physiotherapy in Unilateral Vestibular Hypofunction Patients
|
N/A | |
| Completed |
NCT02938221 -
Telemedical Examination of a Three-Component Oculomotor Testing Battery
|
N/A | |
| Active, not recruiting |
NCT02655575 -
Assessment and Treatment of Patients With Long-term Dizziness in Primary Care
|
N/A | |
| Completed |
NCT02457455 -
Urgent Medical and Surgical Conditions During Flights
|
N/A | |
| Enrolling by invitation |
NCT01426932 -
The Head Impulse Test in the Screening of Vestibular Function
|
N/A | |
| Completed |
NCT00000359 -
Treatments for Benign Paroxysmal Positional Vertigo (BPPV)
|
Phase 2 | |
| Not yet recruiting |
NCT06010550 -
Validating a Clinical Decision Support Tool for Stratifying Stroke Risk for Dizziness/Vertigo
|
||
| Not yet recruiting |
NCT06017466 -
Translation and Implementation of the Dutch VVAS Score in Clinical Practice
|
N/A | |
| Completed |
NCT04598113 -
Effect of Cervical Traction on Balance in Cervical Radiculopathy Patients
|
N/A | |
| Completed |
NCT05157399 -
Quantification of the Effect of the OtoBand on Objective Measures of Vertigo and Dizziness
|
N/A | |
| Completed |
NCT05897853 -
Impact of Vertigoheel® on Patients Suffering From Bilateral Vestibulopathy and Functional Dizziness
|
||
| Completed |
NCT05221892 -
Evaluation of Aminobutyric Acid, Glutamic Acid, Calcium, Thiamine, Pyridoxine and Cyanocobalamin as Therapy for Vertigo
|
Phase 4 |